Autoimmune encephalitis: A costly condition

Jesse Cohen, Javier Sotoca, Shikha Gandhi, Anusha K. Yeshokumar, Eliza Gordon-Lipkin, Romergyko G. Geocadin, Kevin Frick, John C Probasco, Arun Venkatesan

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To assess the inpatient hospitalization burden and costs of patients with autoimmune encephalitis (AE) at a tertiary care institution. METHODS: Adult inpatients with AE were identified retrospectively from July 1, 2005, to June 30, 2015. Demographic and clinical data were collected and analyzed. Billing data were compared to those of patients with herpes simplex encephalitis (HSE). Charges were adjusted for inflation. RESULTS: Of 244 admissions for encephalitis reviewed, 63 patients met criteria for probable or definite AE. Thirty-one (49%) patients were antibody positive, and 27 (43%) were admitted to the intensive care unit (ICU). Median hospital charges per patient with AE were more than $70,000; median length of stay (LOS) was 15 days; and in-hospital mortality was 6%. Patients admitted to the ICU had substantially higher median hospital charges (ICU $173,000 per admission vs non-ICU $50,000 per admission, p < 0.001). LOS was strongly associated with charges and was driven by delay in diagnosis of AE, prolonged treatment courses, and lack of response to therapy. Compared with HSE, median hospital charges per patient with AE were nearly 4 times higher, median AE LOS was 3 times higher, and total charges over the study period were nearly twice as high. CONCLUSIONS: Patients with AE used more inpatient health care resources per patient during a 10-year period than patients with HSE at our institution. ICU-admitted patients with AE were responsible for a substantially higher financial burden than non-ICU-admitted patients with AE. Our data underscore the need for the development of novel diagnostic and therapeutic modalities to improve patient outcomes and to decrease hospital burden in AE.

Original languageEnglish (US)
Pages (from-to)e964-e972
JournalNeurology
Volume92
Issue number9
DOIs
StatePublished - Feb 26 2019

Fingerprint

Herpes Simplex Encephalitis
Hospital Charges
Intensive Care Units
Inpatients
Length of Stay
Hashimoto's encephalitis
Health Resources
Economic Inflation
Encephalitis
Tertiary Healthcare
Hospital Mortality
Hospitalization
Therapeutics
Demography
Delivery of Health Care
Costs and Cost Analysis
Antibodies

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Cohen, J., Sotoca, J., Gandhi, S., Yeshokumar, A. K., Gordon-Lipkin, E., Geocadin, R. G., ... Venkatesan, A. (2019). Autoimmune encephalitis: A costly condition. Neurology, 92(9), e964-e972. https://doi.org/10.1212/WNL.0000000000006990

Autoimmune encephalitis : A costly condition. / Cohen, Jesse; Sotoca, Javier; Gandhi, Shikha; Yeshokumar, Anusha K.; Gordon-Lipkin, Eliza; Geocadin, Romergyko G.; Frick, Kevin; Probasco, John C; Venkatesan, Arun.

In: Neurology, Vol. 92, No. 9, 26.02.2019, p. e964-e972.

Research output: Contribution to journalArticle

Cohen, J, Sotoca, J, Gandhi, S, Yeshokumar, AK, Gordon-Lipkin, E, Geocadin, RG, Frick, K, Probasco, JC & Venkatesan, A 2019, 'Autoimmune encephalitis: A costly condition' Neurology, vol. 92, no. 9, pp. e964-e972. https://doi.org/10.1212/WNL.0000000000006990
Cohen J, Sotoca J, Gandhi S, Yeshokumar AK, Gordon-Lipkin E, Geocadin RG et al. Autoimmune encephalitis: A costly condition. Neurology. 2019 Feb 26;92(9):e964-e972. https://doi.org/10.1212/WNL.0000000000006990
Cohen, Jesse ; Sotoca, Javier ; Gandhi, Shikha ; Yeshokumar, Anusha K. ; Gordon-Lipkin, Eliza ; Geocadin, Romergyko G. ; Frick, Kevin ; Probasco, John C ; Venkatesan, Arun. / Autoimmune encephalitis : A costly condition. In: Neurology. 2019 ; Vol. 92, No. 9. pp. e964-e972.
@article{d08f385b506042bc8ed307ed3067319e,
title = "Autoimmune encephalitis: A costly condition",
abstract = "OBJECTIVE: To assess the inpatient hospitalization burden and costs of patients with autoimmune encephalitis (AE) at a tertiary care institution. METHODS: Adult inpatients with AE were identified retrospectively from July 1, 2005, to June 30, 2015. Demographic and clinical data were collected and analyzed. Billing data were compared to those of patients with herpes simplex encephalitis (HSE). Charges were adjusted for inflation. RESULTS: Of 244 admissions for encephalitis reviewed, 63 patients met criteria for probable or definite AE. Thirty-one (49{\%}) patients were antibody positive, and 27 (43{\%}) were admitted to the intensive care unit (ICU). Median hospital charges per patient with AE were more than $70,000; median length of stay (LOS) was 15 days; and in-hospital mortality was 6{\%}. Patients admitted to the ICU had substantially higher median hospital charges (ICU $173,000 per admission vs non-ICU $50,000 per admission, p < 0.001). LOS was strongly associated with charges and was driven by delay in diagnosis of AE, prolonged treatment courses, and lack of response to therapy. Compared with HSE, median hospital charges per patient with AE were nearly 4 times higher, median AE LOS was 3 times higher, and total charges over the study period were nearly twice as high. CONCLUSIONS: Patients with AE used more inpatient health care resources per patient during a 10-year period than patients with HSE at our institution. ICU-admitted patients with AE were responsible for a substantially higher financial burden than non-ICU-admitted patients with AE. Our data underscore the need for the development of novel diagnostic and therapeutic modalities to improve patient outcomes and to decrease hospital burden in AE.",
author = "Jesse Cohen and Javier Sotoca and Shikha Gandhi and Yeshokumar, {Anusha K.} and Eliza Gordon-Lipkin and Geocadin, {Romergyko G.} and Kevin Frick and Probasco, {John C} and Arun Venkatesan",
year = "2019",
month = "2",
day = "26",
doi = "10.1212/WNL.0000000000006990",
language = "English (US)",
volume = "92",
pages = "e964--e972",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Autoimmune encephalitis

T2 - A costly condition

AU - Cohen, Jesse

AU - Sotoca, Javier

AU - Gandhi, Shikha

AU - Yeshokumar, Anusha K.

AU - Gordon-Lipkin, Eliza

AU - Geocadin, Romergyko G.

AU - Frick, Kevin

AU - Probasco, John C

AU - Venkatesan, Arun

PY - 2019/2/26

Y1 - 2019/2/26

N2 - OBJECTIVE: To assess the inpatient hospitalization burden and costs of patients with autoimmune encephalitis (AE) at a tertiary care institution. METHODS: Adult inpatients with AE were identified retrospectively from July 1, 2005, to June 30, 2015. Demographic and clinical data were collected and analyzed. Billing data were compared to those of patients with herpes simplex encephalitis (HSE). Charges were adjusted for inflation. RESULTS: Of 244 admissions for encephalitis reviewed, 63 patients met criteria for probable or definite AE. Thirty-one (49%) patients were antibody positive, and 27 (43%) were admitted to the intensive care unit (ICU). Median hospital charges per patient with AE were more than $70,000; median length of stay (LOS) was 15 days; and in-hospital mortality was 6%. Patients admitted to the ICU had substantially higher median hospital charges (ICU $173,000 per admission vs non-ICU $50,000 per admission, p < 0.001). LOS was strongly associated with charges and was driven by delay in diagnosis of AE, prolonged treatment courses, and lack of response to therapy. Compared with HSE, median hospital charges per patient with AE were nearly 4 times higher, median AE LOS was 3 times higher, and total charges over the study period were nearly twice as high. CONCLUSIONS: Patients with AE used more inpatient health care resources per patient during a 10-year period than patients with HSE at our institution. ICU-admitted patients with AE were responsible for a substantially higher financial burden than non-ICU-admitted patients with AE. Our data underscore the need for the development of novel diagnostic and therapeutic modalities to improve patient outcomes and to decrease hospital burden in AE.

AB - OBJECTIVE: To assess the inpatient hospitalization burden and costs of patients with autoimmune encephalitis (AE) at a tertiary care institution. METHODS: Adult inpatients with AE were identified retrospectively from July 1, 2005, to June 30, 2015. Demographic and clinical data were collected and analyzed. Billing data were compared to those of patients with herpes simplex encephalitis (HSE). Charges were adjusted for inflation. RESULTS: Of 244 admissions for encephalitis reviewed, 63 patients met criteria for probable or definite AE. Thirty-one (49%) patients were antibody positive, and 27 (43%) were admitted to the intensive care unit (ICU). Median hospital charges per patient with AE were more than $70,000; median length of stay (LOS) was 15 days; and in-hospital mortality was 6%. Patients admitted to the ICU had substantially higher median hospital charges (ICU $173,000 per admission vs non-ICU $50,000 per admission, p < 0.001). LOS was strongly associated with charges and was driven by delay in diagnosis of AE, prolonged treatment courses, and lack of response to therapy. Compared with HSE, median hospital charges per patient with AE were nearly 4 times higher, median AE LOS was 3 times higher, and total charges over the study period were nearly twice as high. CONCLUSIONS: Patients with AE used more inpatient health care resources per patient during a 10-year period than patients with HSE at our institution. ICU-admitted patients with AE were responsible for a substantially higher financial burden than non-ICU-admitted patients with AE. Our data underscore the need for the development of novel diagnostic and therapeutic modalities to improve patient outcomes and to decrease hospital burden in AE.

UR - http://www.scopus.com/inward/record.url?scp=85062173425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062173425&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000006990

DO - 10.1212/WNL.0000000000006990

M3 - Article

VL - 92

SP - e964-e972

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 9

ER -